Medicare beneficiaries face higher costs, reduced services, and possible cuts to the program at large—but there’s good news ...

Medicare Part D drugs for conditions like cancer/diabetes will have lower, negotiated prices starting Jan 1, 2026, saving ...

The Trump administration is turning to an unconventional approach to lowering drug prices in the United States: striking ...

Consumers have one major defense against rising costs, shrinking provider networks and disappearing benefits: Medicare’s fall ...

A provision of the summer’s One Big Beautiful Bill Act bumping a slew of orphan drugs from Medicare price negotiation is ...

The One Big Beautiful Bill Act removed a number of orphan drugs from being subject to price negotiations, and this could cost ...

Prescription drug costs are skyrocketing. Will Medicare Part D bring relief? The law of supply and demand dictates that when competition is scarce, prices will inevitably skyrocket. In the health care ...

Seniors enrolling in Medicare for 2026 should brace for sharply higher prescription drug prices and fewer policies from which ...

Medicare costs are rising significantly in 2026, with Part B premiums set for one of the largest hikes in the program's ...

CheapInsurance.com reports that a new $2,000 out-of-pocket cap under Medicare Part D will save millions, but challenges remain in drug pricing and access.